Status:
RECRUITING
Cerebellar tDCS in Children With Autism Spectrum Disorder
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
United States Department of Defense
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
4-17 years
Phase:
NA
Brief Summary
The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorde...
Detailed Description
The study will be randomized, double-blind, and controlled. It will involve a group of 60 children with ASD (diagnosed with the Autism Diagnostic Observation Schedule (ADOS-2) by a research-reliable c...
Eligibility Criteria
Inclusion
- 4-17 years old
- Diagnosed with ASD and ADOS-2
- IQ Score no less than 70 (1.5 Standard Deviations below the mean)
- Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences)
Exclusion
- Brain implants, metal implants, pacemakers, or biomedical devices
- Diagnosis of epilepsy
- Hearing or visual impairments
- History of brain injury
- Known brain abnormalities not associated with ASD
Key Trial Info
Start Date :
June 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04446442
Start Date
June 4 2019
End Date
March 31 2026
Last Update
May 1 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Medical Center
Dallas, Texas, United States, 75235
2
University of Texas Southwestern
Dallas, Texas, United States, 75390